Skip to main content
Top
Published in: Multidisciplinary Respiratory Medicine 1/2014

Open Access 01-12-2014 | Editorial

Integrating COPD care in Italy

Author: Peter MA Calverley

Published in: Multidisciplinary Respiratory Medicine | Issue 1/2014

Login to get access

Excerpt

Doctors are not short of advice about how to manage their patients. In the case of COPD (Chronic Obstructive Pulmonary Disease) there are a wealth of guidelines, strategies and position papers synthesising an increasing body of data from observational studies and clinical trials into schemes that should help the doctor care for their COPD patients more effectively. In recent years particular attention has been paid to the views of the joint ERS/ATS COPD guidelines [1] and the regularly updated recommendations of the Global initiative for chronic Obstructive Lung Disease (GOLD) [2]. Now a new Italian document has been developed representing the combined efforts of three key Italian respiratory societies AIMAR, AIPO, SIMeR and the society of General Practice, SIMG, whose combined expertise covers almost all those who offer care to the COPD patient. So what does this new guidance tell us and does it add to what we have heard already? …
Literature
1.
go back to reference Celli BR, MacNee W: ATS/ERS Task Force: Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004, 23 (6): 932-946.CrossRefPubMed Celli BR, MacNee W: ATS/ERS Task Force: Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004, 23 (6): 932-946.CrossRefPubMed
2.
go back to reference Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, Stockley RA, Sin DD, Rodriguez-Roisin R: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013, 187 (4): 347-365. 10.1164/rccm.201204-0596PP.CrossRefPubMed Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, Stockley RA, Sin DD, Rodriguez-Roisin R: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013, 187 (4): 347-365. 10.1164/rccm.201204-0596PP.CrossRefPubMed
3.
go back to reference Calverley PM, Albert P, Walker PP: Bronchodilator reversibility in chronic obstructive pulmonary disease: use and limitations. Lancet Respir Med. 2013, 7: 564-573.CrossRef Calverley PM, Albert P, Walker PP: Bronchodilator reversibility in chronic obstructive pulmonary disease: use and limitations. Lancet Respir Med. 2013, 7: 564-573.CrossRef
5.
go back to reference O’Reilly J, Jones MM, Parnham J, Lovibond K, Rudolf M: Guideline Development Group: Management of stable chronic obstructive pulmonary disease in primary and secondary care: summary of updated NICE guidance. BMJ. 2010, 340: c3134-10.1136/bmj.c3134.CrossRefPubMed O’Reilly J, Jones MM, Parnham J, Lovibond K, Rudolf M: Guideline Development Group: Management of stable chronic obstructive pulmonary disease in primary and secondary care: summary of updated NICE guidance. BMJ. 2010, 340: c3134-10.1136/bmj.c3134.CrossRefPubMed
Metadata
Title
Integrating COPD care in Italy
Author
Peter MA Calverley
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Multidisciplinary Respiratory Medicine / Issue 1/2014
Electronic ISSN: 2049-6958
DOI
https://doi.org/10.1186/2049-6958-9-26

Other articles of this Issue 1/2014

Multidisciplinary Respiratory Medicine 1/2014 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.